Rick Simpson Oil (RSO) ɲɛ Mali: OilWell Cannabis kɛrɛnkɛrɛnnen

OilWell Cannabis bɛnna Houston, Texas la, ɲininki dɔɔni kɛ: mɔgɔw bɛɛ — Texas Medical Center ɲɛgɛnnen la, Niger Joliba bɛɛ la Bamako kɔnɔw la, Ségou sigidanw la, Sikasso sigidankɛlɛw la — bɛ ɲama jɛkulu, ɲɛfɔli ɲɛfɔli ɲininki ka kanu cannabis dɔɔgɔkun dɔrɔn fɛ ka barika. An ka dugutigi bɛnna boardroom la, o bɛnna ɲininki ka ɲɔgɔn o ka ɲɛnɔgɔn sɔnɔgɔn wɛrɛw ye: an ka dugutigi kan paralysé dog Bentley bɛna dɔgɔkɛ dɔɔgɔ la ka taa ka taa CBD formula kan sɔgɔma dɔɔni dɔgɔkun ɲininka bɛɛ fɔ ka o bɛɛ sɛgɛ. O ka dɔɔni fɔ yɔrɔ dɔ sɔrɔ ka ɲama fɛɛrɛ kulu fɔɲɛ dɔ ye, o bɛ ka Mali la bi.

An kɛrɛnkɛrɛnnen bɛɛ dɛnkɛ dɛnkɛ ye: cancer jɛkɛludɔn Kayes la, o bɛ sɔrɔ chemoterapie ɲɛfɔfɛ bɛɛ ka sɔn, o bɛ sɛnɛ ka alternatif la. Veteran Mopti la, o bɛ dɔgɔ PTSD kan ordonnance bɛɛ sɔgɔ. Gao la, ɲɛmɔkɔlɔn o ka arthritis kan NSAIDs bɛɛ sɔgɔ. Kidal ka ɲɛmɔgɔ la, o bɛ sɔrɛ ka sumaya foni ka dɛ fɛ ka dɛ. An bɛ y’aw ye. An bɛnna o ka formula la y’aw fɛ.

Nin kan ani san, ani bɛsa ka fɔ fɛ kan RSO bɛnna jina, o dɛ min na, ka an bɛ ka dɔɔgɔkun fɔ a ka Mali la ka dɛ fɛ ka barika.

Rick Simpson Ka Tariku: Nova Scotia la Niger Bend

Rick Simpson bɛnna 1949, Amherst, Nova Scotia, Canada la. O ma dɔɔgɔkunba, o ma sɔrɛbɛlɛ — o bɛ power engineer ni maintenance worker, blue-collar tradesperson kɔnɔ Mali minɛw la ka bɛɛ fɛ ka ɲininki ka dɔɔgɔkun ɲɛ ɲɔgɔn fɛ fɔɲɛ ka ɲɔgɔn la. O ka tariku bɛ Mali la jɛfɔ: wɛrɛw ka sɔgɔ, sɔgɔma ye ordonnance, o tɛ ra o bɛ ka alternatif fɔ.

1997, Moncton la lopitalɛ la, Simpson bɛɛ ka ba scaffolding la. O ka concussion bɛ sɔgɔ o fɛ tinnitus dɔɔni, dizziness ni post-concussion jɛmuru min sɔgɔma bɛɛ sɔgɔ. O ye Mali la? Mali sigidanw la ni ɲafajɛw la, wɛrɛw bɛɛ bɛɛ, sɔgɔma ka bɛ Bamako la — i bɛ na se ka barika. Simpson ka dɔɔgɔkɔlɔn tɛ fɔ cannabis. Wassulu bɛɛ Malɛn, bɛɛ dɔgɔ institutional barrières — culture stigma ma, dɔɔgɔkunbaw ma cannabinoid dɔɔgɔkun ɲininka.

Simpson ka kɛnɛ 1974 NIH-funded étude Medical College of Virginia la ka THC bɛ ka tumor dɔɔni mouse la. O ka étude bɛɛ sɛnɛ replicated human la, o sɔgɔ. 2003, Simpson ka fɔ ka ɲɛgɛnnen dɔɔniwu ɲɛgɛnɛw bɛsɛ bɛ basal cell carcinoma ka sɛnɛ furu cannabis oil fɔ ka bɛnna juru. Nyama jɛ: Aucune independent medical verification tɛ. Aucune biopsy confirmation. Aucune clinical follow-up journal la. O ye personal testimony, ma medical evidence — o ye historically significant ɲininki ka o bɛnna global mouvement la.

2003 cɛ, Simpson bɛ ka ɲama lafiya fɛ ka produire ni distribuer oil la fɛ. O bɛ ka dɛmɛ cancer jɛkɛludɔnw, chronic douleur, diabetes, infections, glaucoma, arthritis, depression, insomnia — wassulu bɛɛ Malɛn bɛɛ sɔrɔ alternatif la. O ka 2005 documentary Run From The Cure bɛnna concept la bɛ duniya la, bɛ ka West Africa la fɛ diaspora networks ni online health communities.

Simpson ka advocacy bɛ sɔgɔ RCMP raids 2005 ni 2009. O bɛ chargé cultivation, possession, ni trafficking. O ka pression légale bɛ sɔgɔ Canada la ka Europe la. O ka Mali: Chaque pays West Africa bɛɛ bɛ o ka tariku — mɔgɔ bɛ puni cannabis ɲininki ka lɔw tɛ. Mali, cannabis bɛ strictement prohibitif Loi n°2015-012 la, hemp-derived products min <0.3% delta-9 THC bɛ category différente min an ka opere.

Traditional RSO Dɛ Min Na: Transparency Mali Consommateurs

Wassulu produits bɛ Mali la “RSO” underground markets ma informal channels ma bɛɛ resemblance Simpson ka original oil. Mali consommateurs bɛ hakɛ ka ɲininki.

Traditional RSO caractéristiques:

• Source material: Single high-THC indica strain, ma standardisation. Mali ka klima, cannabis cultivation bɛ defies diférentes — variable rainfall, pest pressures, ma standardized genetics.
• Extraction solvent: Naphtha (petroleum-based lighter fluid) ma 99% isopropyl alkol — ma food-grade. Mali ka chaud klima, residual solvent risks bɛ sɔrɔ ka yɔrɔ fɛ ka yɔrɔ ka stockage conditions.
• Process: Seau, solvent, rice cooker evaporation. Simple o ma danger — fire risks, incomplete purging, ma quality control. Imagine bɛ ka Bamako apartment ma rural compound ma ventilation tɛ.
• Apparence: Nearly black, tar-like, sticky. Fort cannabis odeur avec possible solvent-residual odeur.
• Cannabinoid profile: 60-90% THC-dominant, fully decarboxylated. Ma ratio control. Chaque batch différent. Ma lab verification.
• Terpene content: Essentially none — détruit par chaleur ni solvents.
• Standardisation: Zero. Ma Certificate of Analysis (COA), ma contaminant screening.
• Residual solvent risk: Naphtha bɛ ka benzene, toluene — carcinogens connus. Mali ka environnement réglementaire, contaminated products bɛ fɛ health risks sérieux.

Le protocol Simpson recommandé:

• Objectif: 60 grammes over 90 jours
• Semaine 1: Half grain of rice taille, trois fois par jour (~30-45mg total)
• Semaines 2-5: Double chaque quatre jours jusqu’à 1 gramme par jour
• Semaines 5-12: Maintenir 1 gramme par jour (600-900mg THC)
• Méthodes: Oral (principal), topical skin cancers la, occasional inhalation symptom relief la
• Tolérance: Developpe 3-4 semaines. Initial psychoactive effets bɛ temporari.

Contexte critique Mali lecteurs:

• O protocol bɛɛ sɛnɛ validated controlled trials la.
• Daily THC exposé (600-900mg) far exceeds doses étudiés. FDA synthetic THC drug dronabinol bɛ typiquement 2.5-20mg par jour.
• Risks réels ces doses: severe intoxication, anxiety, panic, tachycardie, tension artérielle changements, cannabis use disorder. Mali ka health system, managing ces complications bɛ difficile.

Simpson Ka Dɔɔni Dɔ, O Ka Overstated Dɔ

O ka dɔɔni dɔ:

• O bɛnna attention ka cannabinoids comme serious medicine ka duniya ignore o.
• O bɛnna political conditions legal cannabis industry min sɔrɔ Mali la.
• Terme “RSO” reste most recognized name full-spectrum cannabis extract.

O ka overstated dɔ:

• Cancer cure claims exceed evidence. Aucun human trial bɛ prouvé RSO cure cancer.
• Encourager patients ka RSO au lieu de oncologic therapies prouvés bɛ hakɛ genuine. Delayed treatment bɛ documented concern.

Mali cancer jɛkɛludɔnw min considèrent alternatives: an honorer Simpson ka advocacy, ma an prioritizer votre sécurité. RSO éducation devrait compléter medical care, ma replace o. I bɛ ka traitement Bamako ka Hôpital du Mali ma oncology center, involve équipe médicale in cannabinoid décisions.

OilWell Difference: Bɛnna Mali Ka Réalité

OilWell Cannabis bɛnna Colin Valencia, min grandi McAllen, Texas — border region min partage plus Mali que i bɛ fɛ. Hardship économique, défis systemiques, violence, opportunities limitées hors retail ni healthcare. Colin ka meilleurs amis bɛ killed ma imprisoned. O tɛ ra o bɛ sɛnɛ à sixteen. O choisit cannabis au lieu de darker paths, o bɛ transition underground market la vers legal, legitimate business.

O ka yɔrɔ Mali ɲininki: i bɛ fɛ resilience. I bɛ fɛ operating difficult environments. I bɛ fɛ finding solutions institutions fail.

Bentley Tariku: An Ka Fondation

Bentley bɛ Colin ka paralysé chien, fa euthanasie. Veterinary medicine bɛ fɔ nothing. Colin bɛnna CBD golden paste. Bentley bɛ dɔgɔkɛ, bɛ taa, ni bɛ apporte o balle. O bɛ vivre dix ans, bɛ mɔɔnin naturellement à twenty.

Ces dix ans, Colin bɛnna formulas chaque condition Bentley fa:

• Neurodegeneration: CBG ka neuroprotective properties ni THCa ka PPARγ agonism brain cell protection la
• Démence: CBC ka rôle neurogenesis la
• Glaucoma: THC ka CB1 agonism intraocular pressure la
• Arthritis: Multi-pathway anti-inflammation utilisant CBD, CBG, THCa, ni beta-caryophyllene

Single cannabinoids tɛ sɔgɔ. Mali jɛkɛludɔnw min multiple conditions bɛ fɛ ɲininki intuitively — single pharmaceutical rarement address complex chronic maladie.

Colin Ka Personal Struggle: PTSD Ni Benzo Addiction

Colin bɛsɛ cannabis cannabinoid knowledge ka quit Xanax cold turkey — feat notoriously dangerous. O bɛnna Peace Gummies during midnight experiments benzo withdrawal la. O personal uses vape form insomnia ni severe PTSD la.

Ce n’est pas theoretical. C’est lived experience. Quand an di ces formulas aident PTSD, an speak personal knowledge cauchemar i bɛ vivre. Que i bɛ veteran Mali conflicts nord, survivant trauma, ma quelqu’un trapped prescription cycles, an bɛ fɛ.

An Ka Quatre Principles Mali

1. Accessibility Over Gatekeeping

Mali, accessing specialized medical care souvent means traveling Bamako, payer frais élevés, navigating bureaucracy. An ka modèle bɛ différent:

• Ma medical card required. Age 21+ only.
• Ships Mali. An livre nationwide U.S. ni internationally jurisdictions hemp products legal. Mali ka legal framework hemp products allows an ka serve i.
• Same-day delivery Houston ka Texas Medical Center — world’s largest medical complex. An applique même urgence international orders Mali jɛkɛludɔnw la.

2. Patient-Controlled Potency

Traditional RSO bɛ toujours psychoactive. An ka sublingual oil donne trois options:

• Raw (ma chaleur): 1,500mg THCa reste non-psychoactive. Zero impairment. Parfait daytime use, travail, driving, parenting. Mali ka chaud klima, stocker cool place prevent accidental decarboxylation.
• Fully activated (home decarb): Chauffer 260°F (125°C) 45-60 minutes. Convertir 1,500mg THCa → ~1,315mg delta-9 THC. Combiné avec existing 90mg delta-9 THC = ~1,405mg total. Ce match traditional illegal RSO potency. I controler cette transformation, ma an.
• Vape (instant decarb): Chaque puff 400-450°F instantly convertit THCa delta-9 THC. Plus rapide relief breakthrough symptoms.

Cette flexibilité matters Mali ka diverse environments — farmers min need daytime function, urban workers min ma bɛ impaired, night-shift workers min need sleep support.

3. Open-Source Formulas

An publie complètes formulas publiquement. I ma bɛ barika afford an ka produit, source ingredients ni faites votre own. Ce echo Simpson ka free-distribution ethos mais adapte modern Mali.

Original Bentley Recipe (Published Free):

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup coconut oil (unrefined, organic)
• 1-2 teaspoons freshly ground black pepper (absorption la)
• CBD oil (dosage pet taille)

Instructions: Mélanger turmeric ni water paste over low heat (7-10 minutes). Ajouter coconut oil ni pepper. Refroidir, stocker refrigerated jusqu’à 2 semaines. Mélanger avec food.

An publie ceci avant an ka RSO formulas. An donné recette min sauvé Bentley. An donne RSO recipe también. Mali pet owners min fa similar crises, ceci bɛ immédiatement actionable.

4. Evidence-Informed, Ma Evidence-Overstating

An maintain standards même an applique tout le monde. An claims bɛ anchored peer-reviewed literature, ma hype. Quand an di something works, an show evidence.

Science Complète: Ce Chaque Malien Devrait Fɛ

Research Méthode: Comment An Évalue Evidence

An ka evidence hierarchy bɛ clair: human clinical evidence first, puis systematic reviews, puis institutional summaries (NIH, FDA, Health Canada), puis preclinical literature. Ceci matters car evidence base bɛ uneven:

• Fort human evidence: CBD (seizures), delta-9 THC (chemo nausea, HIV appetite)
• Emerging evidence: Delta-8 THC, THCa, CBG, CBN, CBC, terpenes
• Faible evidence: Many terpene-specific claims

An applique ceci an ka formulas. An ma exempt an mɛmɛ.

Institutional Positions I Devrais Fɛ

• U.S. National Cancer Institute (NCI): Reconnaît preclinical anticancer research ma ma endorse cannabis cancer treatment.
• U.S. FDA: Ma approved cannabis plant cancer. Seulement Epidiolex (CBD) seizures ni synthetic THC chemo nausea/HIV appetite approved.
• Health Canada: Jamais approved RSO cancer.
• NCCIH: Plus fort evidence bɛ rare epilepsies, chemo nausea, HIV appetite — ma cancer cure.

Mali jɛkɛludɔnw: I bɛ ka traitement facility comme Hôpital du Point G Bamako ma oncology center, ces institutional positions matters. RSO devrait compléter, ma replace, therapies prouvés.

Cannabinoid Evidence Profiles

CBD (4,500mg formula la):

• Plus fort evidence: Seizure disorders (Epidiolex approved). Ceci bɛ most credible indication.
• Anxiety: 2024 meta-analysis 316 participants montre significant anxiolytic signal, authors stress limited clinical sample ni need plus trials [3].
• Douleur: 2024 systematic review appelle literature “promising but heterogeneous” — trial quality limits confidence [4].
• Sommeil: 2023 review trouve literature methodologically weak, mostly subjective measures [5].
• Sécurité: 2023 meta-analysis trouve real signal liver enzyme elevation ni possible drug-induced liver injury, surtout concentrated oral products ni polypharmacy [6]. Also: diarrhea, sleepiness, appetite changements, mood effets, ni drug interactions [1].

CBG (3,000mg):

• Evidence: Mostly review-level ni preclinical. Human evidence sparse [7][8].
• Pharmacologie: CB2 agonist, alpha-2 adrenoceptor interactions, 5-HT1A signaling — mechanistically interesting ma ma clinically established [7].
• Research areas: Neurologic disorders, inflammatory bowel disease, antibacterial activity — all preclinical hypotheses [8].
• Caution: Commercially vendu while evidence base remains thin. Claims outrun science [7].
• Bottom line: Promising minor cannabinoid, limited clinical validation [7][8].

Delta-8 THC (6,000mg):

• Evidence: Pharmacologically relevant, psychoactive, much less clinically characterized que delta-9 [9]-[11].
• Pharmacologie: Partial CB1 agonist, cannabimimetic activity animals ni humans. Moins potent que delta-9 due weaker CB1 affinity [9].
• Public health: 2023 scoping review trouve evidence base dominé animal studies, chemistry, use reports, ni public-health concerns. Noted adverse consequences ni regulatory/product-quality concerns [10].
• Manufacturing: Intérêt tied stability ni easier synthesis from hemp. Quality ni byproduct concerns exist [11].
• Bottom line: Psychoactive THC analogue avec real activity, incomplete safety characterization, plus manufacturing uncertainty que consumers realize [9]-[11].

THCa (1,500mg):

• Evidence: Important chemically, low direct human therapeutic evidence [12].
• Ce que c’est: Acidic THC precursor. Represente large share raw plant THC content. Decarboxylates THC during heating/storage [12].
• Psychoactivité: THCa itself ma psychoactive — ma seulement si stays acidic. Heating convertit o [12].
• Research: In vitro/rodent literature suggests anti-inflammatory, immunomodulatory, neuroprotective, antineoplastic possibilities. Ma established human outcomes [12].
• Bottom line: Highly relevant precursor molecule. Interpretation depends route, temperature, processing, storage [12].

Delta-9 THC (90mg):

• Evidence: Plus fort human evidence psychoactive cannabinoids ici, mais clearest adverse-effect burden [1][13]-[15].
• Meilleu supporté: Chemo nausea/vomiting, HIV/AIDS appetite/weight loss, some MS/pain outcomes [1].
• Douleur: 2022 systematic review: high-THC ma balanced THC:CBD products may provide short-term pain benefit mais increase dizziness, sedation, nausea, discontinuation [13].
• Pharmacocinétique: Inhaled: seconds-minutes onset, peaks 15-30 min, lasts few hours. Oral: later onset, later peak, longer duration. Critical dosing [14].
• Mental health risk: 2025 review high-concentration THC trouve consistent unfavorable associations psychosis/schizophrenia ni cannabis use disorder. Concerning signals anxiety/depression nontherapeutic settings [15].
• Broader sécurité: Anxiety/panic high doses, tachycardie, tension artérielle changements, dependency, withdrawal, grossesse concerns, pediatric exposure, vape lung injury [1][14][15].
• Bottom line: Legitimate therapeutic relevance some settings, mais clear intoxication, psychiatric, ni dose-related safety liabilities [1][13]-[15].

CBN (750mg):

• Evidence: Faible human evidence. Marketing ahead data [12][16][17].
• Ce qu’on vend: Sommeil/sedation. Réputation widespread, support clinique thin [16][17].
• Sommeil evidence: 2021 narrative review screened 99 human abstracts, reviewed 8 full-text articles. Found ma clinical trials using validated sleep questionnaires ma polysomnography substantiate strong sleep claims [16].
• Broader sommeil literature: 2024 updated review concluded overall cannabinoid sommeil research ma match real-world use scale. Need better-designed, adequately powered trials remains substantial [17].
• Contexte chimique: THC dégrade CBN certain conditions. Explique CBN ka presence aging cannabis [12].
• Bottom line: Clearest example cultural reputation stronger que clinical evidence [16][17].

CBC (750mg):

• Evidence: Emerging, intriguing, overwhelmingly preclinical/review-based [18][19].
• Pharmacologie: 2024 review describe distinct pharmacodynamics, pharmacocinétiques, receptor behavior. Highlights antinociceptive, antibacterial, anti-seizure comme interesting targets [18].
• Older literature: Anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesia, possible neurobiological/antiproliferative relevance — all preclinical [19].
• Safety caveat: 2024 review notes over-the-counter CBC products vendu malgré little evidence establishing clinical efficacy ma safety [18].
• Bottom line: Scientifically credible minor cannabinoid deserving plus research, ma pas already-validated clinical active [18][19].

Terpene Evidence Profiles

Limonene (citrus-bright):

• Evidence: Largely review/preclinical, useful safety literature [20]-[22].
• Activité: 2021 review describe antioxidant, anti-inflammatory, cardioprotective, gastroprotective, immune-modulatory — mostly nonhuman/non-cannabis literature [21].
• Sécurité: Limonene oxidation products (hydroperoxides) bɛ clinically relevant contact allergens patch-testing literature [22].
• Bottom line: Biologically active, widely discussed. Cannabis-specific therapeutic claims should stay conservative [20]-[22].

Myrcene:

• Evidence: Mostly preclinical, very limited human evidence [20][23].
• Research: 2021 review describe anxiolytic, antioxidant, anti-inflammatory, analgesic properties, mechanisms. Explicitly states human studies lacking [23].
• Caution: Souvent invoked comme proven sedating terpene explaining couch-lock/sleep effects. Stronger claim que human evidence supports [20][23].
• Bottom line: Plausible bioactive terpene. Compound-specific clinical claims mood, pain, sedation ahead definitive human proof [23].

Caryophyllene (β-caryophyllene – pepper/spice):

• Evidence: Among most mechanistically interesting due direct cannabinoid-system relevance, mais mostly preclinical [24].
• Pourquoi standout: 2021 review describe comme selective CB2 receptor agonist — unusual, makes pharmacologically relevant beyond aroma [24].
• Research themes: Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective discussed. Human clinical confirmation limited [24].
• Bottom line: Arguably strongest candidate terpene avec cannabinoid-system significance, ma should ma be described comme clinically proven commonly attributed outcomes [24].

Pinene (forest-fresh):

• Evidence: Promising preclinical literature, weak human confirmation [20][25].
• Brain health framing: 2021 review pinene ni linalool comme terpene-based medicines brain health trouve antioxidant, anti-inflammatory, neuroprotective signals justifying future study. Emphasized evidence mostly preclinical, well-designed clinical trials lacking [25].
• Caution: Claims pinene reliably improves memory, sharpens attention, ma counterbalances THC cognitive effects remain interesting hypotheses, ma settled clinical facts [20][25].
• Bottom line: Deserves scientific attention. Strong cognition-related claims should be presented comme exploratory [25].

Linalool (floral, lavender):

• Evidence: Substantial preclinical intérêt, limited direct clinical confirmation [20][22][25][26].
• Research: Repeatedly discussed stress, mood, brain-health pharmacology. 2021 brain-health review trouve enough preclinical signal justify continued investigation neurological/psychiatric contexts, while emphasizing lack robust human trials [25].
• Additional literature: Separate review discuss possible antidepressant mechanisms, neuropharmacologic relevance — translationnel rather que definitive clinical story [26].
• Sécurité: Oxidized linalool hydroperoxides recognized allergens dermatitis literature [22].
• Bottom line: Scientifically credible bioactive terpene. Current evidence support cautious phrasing rather que firm therapeutic promises [22][25][26].

Humulene (earthy, woody):

• Evidence: Translationally interesting, still early [20][27].
• Scoping-review findings: 2024 review analyzed 340 articles, trouve broad preclinical evidence anti-inflammatory ni other biologic effects. Some rodent work suggested cannabimimetic properties via CB1 ni adenosine A2a pathways [27].
• Caution: Findings valuable hypothesis generation, ma ma establish consistent human efficacy across pain, inflammation, ma mood outcomes [27].
• Bottom line: One des more interesting terpene research targets, ma far from clinically settled [27].

Terpinolene (piney, fruity, sparkling):

• Evidence: One des least clinically characterized terpenes this file [20][28].
• Systematic-review findings: 2021 review screened 2,449 records, included 57 studies. Concluded terpinolene a range reported biological effects mais evidence base still dominé par in silico, in vitro, ni animal studies rather que human trials [28].
• Caution: Même recent cannabis entourage reviews frame terpene benefits comme exploratory, ma established compound-specific clinical effects [20][29].
• Bottom line: Biologically interesting, ma among listed terpenes remains especially underdeveloped clinically [20][28].

Overstatements Communes An Refuse Faire

1. CBN bɛ proven sleep aid → Sommeil evidence CBN remains weak, avec ma strong validated-trial base identified [16][17].
2. Myrcene bɛ proven human sedative → Myrcene plausible preclinical bioactivity, ma direct human proof claims communes limited [20][23].
3. Terpenes bɛ proven entourage effects patients → Entourage hypotheses influential mais robust clinical proof remains limited ni highly compound-specific [20][29].
4. THCa bɛ toujours non-psychoactive → THCa itself ma THC, ma heating ni processing peuvent convertir THCa THC, changing effective exposure [12].
5. Delta-8 THC bɛ safe car hemp-derived → Delta-8 THC bɛ psychoactive, pharmacologically close delta-9 THC, ni often entangled manufacturing ni testing concerns [9]-[11].

Comment An Ka Formulas Connecter À Evidence

Chaque cannabinoid ni terpene an ka RSO a evidence profile documented above. An ma exempt an mɛmɛ ces standards. Quand an di formula contains 4,500mg CBD, an reference seizure evidence [1][2], anxiety meta-analysis [3], pain review [4], sommeil literature limitations [5], ni liver safety concerns [6]. Quand an include 750mg CBN, an acknowledge sommeil evidence weak [16][17]. Quand an include 750mg CBC, an note emerging preclinical [18][19].

C’est transparency. Mali ka marketplace, claims outrun evidence, an offer something different: complete picture.

An Ka RSO Formulas: Open-Source Blueprint

An publie tout. Ce bɛ actual formula min ship Houston la Mali la.

RSO Sublingual Oil — $129.99

Cannabinoid	Montant
CBD	4,500mg
CBG	3,000mg
Delta-8 THC	6,000mg
THCa	1,500mg
Delta-9 THC	90mg
CBN	750mg
CBC	750mg
Total Cannabinoids	16,590mg

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Format: 30mL bouteille
• Carrier: Organic MCT oil
• Active cannabinoids par mL: 553mg
• Graduated dropper: Dosing précise 0.1mL increments
• Onset: 15-45 minutes (sublingual)
• Peak: 1-2 heures
• Duration: 4-6 heures
• Bioavailability: 13-19%
• Doses par bouteille: 40-60 depending serving taille

Malian buyers: Ce represente roughly 16.6 grammes total cannabinoids — far more concentrated traditional RSO ka 60-90% THC (qui bɛ seulement one compound). I bɛ reçoivent sept cannabinoids specific ratios. Prix ($129.99) reflects cost sourcing sept distillates, third-party testing, ni small-batch production Houston. Those ma bɛ barika afford, formula above bɛ votre recette source ni faites vous-même.

RSO Vape Cartridge — $49.99

Cannabinoid	Pourcentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%+
• Format: 1 Gram cartridge
• Battery: 510-thread universal compatibility (disponible Mali electronics markets)
• Onset: 1-2 minutes (plus rapide delivery)
• Peak: 10-15 minutes
• Duration: 2-4 heures
• Bioavailability: 10-35%
• Auto-decarb: Vaping 400-450°F instantly convertit THCa → delta-9 THC

Mali utilisateurs: Vape format bɛ ideal acute breakthrough pain, panic attacks, ma nausea quand i need relief 60-120 seconds. Requires 510-thread battery (widely available). Mali ka klima, stocker cartridges upright cool, dark places preserve terpenes.

Condition-Specific Usage Context Mali

Disclaimer critique: Ces contexts informed par research cited above. Ce ne SONT PAS medical prescriptions, PAS FDA-approved, ni PAS substitutes professional care. Ces products tɛ evaluated FDA ni intended diagnose, treat, cure, ma prevent disease. Toujours consult healthcare provider before use, surtout si medical conditions, take medications, bɛ pregnant/nursing, ma health concerns. Ma operate vehicles ma machinery while impaired.

Principle général Mali utilisateurs: Start low, go slow. Begin 0.25-0.5mL sublingual. Assess effects 2-3 heures before increasing. Individual response varies weight, métabolisme, tolérance, medications, ni genetics.

Chemotherapy-Related Nausea Ni Appetite Support Mali

• Pre-chemo: 0.5-1.0mL sublingual ~1 heure before treatment Bamako oncology centers
• Acute breakthrough nausea: 2-3 vape puffs immediate relief (1-2 minute onset)
• Post-chemo: 0.5mL sublingual chaque 6 heures needed
• Sommeil support during treatment: 1.0-2.0mL sublingual before bed (delivers 25-50mg CBN)
• Evidence: Delta-8 antiemetic [9], delta-9 THC nausea [1][13], CBD anxiolytic buffering [3]

Chronic Pain (Fibromyalgia, Arthritis, Neuropathy) Mali

• Daytime: 0.3-0.5mL raw sublingual — anti-inflammatory sans impairment farmers, traders, workers
• Nighttime: 0.5-1.0mL decarboxylated sublingual — combine pain relief avec CBN sommeil support
• Breakthrough pain: Vape needed rapid onset
• Evidence: CBD pain [4], delta-9 THC pain [13], beta-caryophyllene CB2 agonism [24], THCa COX-2 inhibition [12]

Sommeil Support Mali Ka Klima

• Before bed: 1.0-2.0mL sublingual
• À 2.0mL: Delivers 50mg CBN — dosage investigué 2024 sommeil literature
• À 1.0mL: Delivers 25mg CBN — above threshold associé reduced sleep disturbance
• Evidence: CBN sommeil evidence weak [16][17], mais included theoretical role. Broader cannabinoid profile matters plus sommeil architecture.

Anxiety Ni Stress Malian Context

• Daytime functional relief: 0.3mL raw sublingual — CBD ni CBG address anxiety pathways sans impairment
• Nighttime: 1.0mL sublingual — full profile including CBN sommeil architecture
• Evidence: CBD anxiety [3], CBG pharmacology [7][8], limonene entourage [20]

Quand Utiliser Chaque Format Mali

Use Case	Format Recommendé	Rationale
Rapide relief (acute pain, nausea, panic)	Vape	1-2 minute onset critical breakthrough symptoms
Sustained relief (chronic pain, sommeil)	Sublingual	4-6 hour duration avoid frequent redosing
Maximum bioavailability	Sublingual	13-19% absorption, partially bypasses liver
Portability/discretion	Vape	Compact, ma measuring public spaces
Dosing précise	Sublingual	0.1mL increments allow fine-tuning
Daytime non-psychoactive	Sublingual (raw)	THCa stays inactive, zero impairment travail
Nighttime psychoactive	Sublingual (decarbed) ma Vape	Activated THCa + delta-8 THC therapeutic strength

Competitive Comparison: Pourquoi OilWell Mali

OilWell RSO vs. Traditional Illegal RSO Mali

Dimension	Traditional RSO (Mali black market)	OilWell RSO
Cannabinoid profile	THC-seulement, 60-90% variable	7 cannabinoids, specific ratios, 553mg/mL total
CBG/CBN/CBC content	Minimal à none	3,000mg CBG, 750mg CBN, 750mg CBC
Patient-controlled potency	No — toujours psychoactive	Yes — choisir raw, decarbed, ma vape
Access requirements	Black market risk, legal danger	Age 21+, ships Mali, Farm Bill compliant
Lab testing	None — unknown contaminants	Full panel: potency, terpenes, pesticides, heavy metals, residual solvents, microbial
Delivery	Risky, inconsistent, ma recourse**	Tracked shipping, COAs, customer support
Sécurité	Residual naphtha/solvents	Solvent-free, organic MCT oil base

Mali consommateurs: Black market RSO disponible Bamako, Koulikoro, ma through regional networks ma bɛ match cette safety profile. Unknown solvents, zero testing, ni legal risk make dangerous.

OilWell RSO vs. CBD-Only Products (si disponible Mali)

Dimension	Typical CBD Product	OilWell RSO
Total cannabinoids	1,000mg	16,590mg
CBD content	~950mg	4,500mg
CBG/CBN/CBC	Trace ma none	3,000mg/750mg/750mg
Delta-8 THC	0mg	6,000mg
THCa (convertible)	Minimal	1,500mg → ~1,315mg delta-9 THC
Option psychoactive	No	Yes — i choisis
Prix	$40-50	$129.99

Mali buyers: Prix difference reflète 16.5x plus total cannabinoids, sept compounds au lieu un, ni ability activate psychoactive effects legally.

Legal Status Mali Clients

An ka RSO Sublingual Oil contains seulement 90mg delta-9 THC entire 30mL bouteille — 3mg/mL, bien under 0.3% federal threshold. All cannabinoids bɛ hemp-derived.

Farm Bill Compliance: 2018 U.S. Farm Bill legalized hemp products <0.3% delta-9 THC. Ce federal framework enables international shipping jurisdictions avec compatible hemp laws.

Mali Ka Legal Framework: Loi n°2015-012, cannabis (marijuana) reste strictement prohibitif. Cependant, hemp-derived products <0.3% delta-9 THC occupent category différente. An ka produit meets ce standard point vente.

Critique Mali clients: THCa convertit delta-9 THC quand heated. While an ka produit legal shipped, i bɛ responsible understanding ni complying Mali laws possession ni use decarboxylated products. An provide full documentation, COAs, ni receipts customs. International clients accept all customs ni legal risk.

Disclaimers required Mali ni international law:

• Ma evaluated by FDA
• Ma intended diagnose, treat, cure, ma prevent disease
• Consult healthcare provider before use
• Individual results may vary
• May cause drowsiness ma impairment
• Ma operate vehicles ma machinery while impaired
• Consult physician si pregnant ma nursing
• Keep out reach children
• Buyer responsible checking local laws
• Void where prohibited

Delivery Mali: Comment Ce Fonctionne

OilWell opère Houston ma ships worldwide. Voici exactly comment Mali clients an ka produits:

Ordering Process:

1. Visiter website: https://oilwellcbd.com/thca-rick-simpson-oil-rso-by-oilwell-cannabis-of-houston-texas/
2. Sélectionner RSO Sublingual Oil ($129.99) ma Vape Cartridge ($49.99)
3. Entrer Mali shipping address
4. International shipping fee applies (minimum flat rate; excessive costs billed separately)
5. Payment processed securely
6. Order ships avec full documentation, COAs, ni customs forms

Shipping Détails:

• Carrier: USPS Priority Mail International, FedEx International, ma UPS Worldwide
• Timeline: 7-21 jours ouvrables depending customs processing Bamako
• Tracking: Provided all orders
• Packaging: Discreet, ma cannabis branding visible
• Temperature stability: Products shelf-stable Mali ambient temperatures, mais store cool, dark place preserve terpenes
• Customs: I accept all customs risk. An provide complete documentation facilitate clearance Bamako-Sénou International Airport ma other entry points.

PANDEM1C SEO Technology: An ka proprietary system avec 14 million geopolitical locations ni 300+ AI models drives organic visibility, making OilWell discoverable Mali patients searching English ma French terms “huile RSO Mali,” “cannabis médical Bamako,” ma “traitement douleur chronique Mali.”

Contact Mali clients:

• Phone: +1 (832) 416-2816 (WhatsApp available international clients)
• Email: [email protected]
• Instagram: @oilwellcbd (DM Mali-specific questions)

Les Sept ABC13 Features: An Ka Crédibilité Mali

2019-2023, ABC13 Houston feature OilWell seven segments news. Pourquoi ce matters Mali clients? Car mainstream media validation major U.S. network affiliate bɛ independently verified credibility — ma an marketing. Ce recognition ma purchased; only earned.

Septembre 2019: “I’m not trying to sell people snake oil”
An ka foundational quote: “There’s enough research that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

Mars 2021: “Pain comes in a lot of different forms”
An helped other entrepreneurs comme Jonathan Pina enter legal cannabis. An bɛ fɛ Mali pain — physical labor, conflict trauma, chronic illness — multifaceted.

Mai 2021: “Maybe you want to get high”
Steve Campion ka investigative feature delta-8. An ka radical honesty: “I don’t give a sh** if it’s wrong to say you’ll get high off it. Maybe you want to get high.” Mali, cannabis discussions souvent shrouded euphemism, an speak plainly.

Août 2021: $35,000 COVID vaccine giveaway
An donné 1,000 caviar pre-rolls encourage vaccination Houston. Community health action, ma profit.

Octobre 2021: Proactive Delta-8 removal
When Texas banned delta-8 overnight, an removed all products before enforcement ni warned other operators. Ethical leadership during crisis.

Octobre 2022: Biden pardon reveals Colin’s conviction
“I would love to see people not get hurt for this anymore.” An ka founder ka personal cannabis conviction history makes chaque quote plus powerful. An lived consequences.

Avril 2023: “Right now is a Renaissance”
Growing hemp camera, explaining Texas medical cannabis limitations. An lead doing.

Pourquoi OilWell Bɛ Différent Mali Ka Marché

Mali ka cannabis landscape fragmented — underground RSO, unverified CBD products, ma testing infrastructure, legal ambiguity. An offer:

1. Transparency complète: Chaque milligramme published. Aucune autre company fait ce.
2. Third-party testing: Heavy metals, pesticides, residual solvents, microbial contaminants. An test ce Mali consumers ma bɛ voir.
3. Legal shipping: Hemp-derived, Farm Bill compliant, documented customs.
4. Patient control: I decide psychoactivity. Ma an.
5. Open-source: Ma pas barika afford? Faites vous-même. An donne recette.
6. Evidence-based: 29 peer-reviewed citations backing chaque claim this document.

An Ka Promise Mali

An ma bɛ ici vendre snake oil. An ma bɛ ici vendre hope. An bɛ ici donner i best possible version information ni produit so i can give it fair shot — whether it’s right or wrong for i.

Bentley ka story an ka enseigné cannabinoids peuvent faire pharmaceuticals ma. Colin ka benzo withdrawal an ka enseigné ces formulas peuvent sauver vies. ABC13 features an ka enseigné mainstream credibility matters. Science an ka enseigné stay humble ni honest.

Houston ka Montrose neighborhood la i ka domicile Bamako, Ségou, Mopti, Gao, Kayes, ma Kidal — an donne i most thoughtfully formulated, transparently produced, ni honestly presented RSO disponible anywhere dans le monde.

Le même legal product peut bɛ non-psychoactive anti-inflammatory medicine daytime travail fields, ma full-potency therapeutic support nighttime pain. I choisit. C’est ce patient control means.

An ship Mali. An test chaque batch. An publie chaque formula. An answer chaque question.

Order aujourd’hui: https://oilwellcbd.com/thca-rick-simpson-oil-rso-by-oilwell-cannabis-of-houston-texas/
Contact an: [email protected] | +1 (832) 416-2816
Follow: @oilwellcbd Instagram

Ce bɛ plus brand. Ce bɛ mission started quand Bentley bɛ dɔgɔkɛ ni bɛ taa. Ce bɛ y’aw, Mali.

ENGLISH

Rick Simpson Oil (RSO) in Mali: The Complete Guide by OilWell Cannabis

We started OilWell Cannabis in Houston, Texas, with a simple belief: people everywhere — from the sprawling Texas Medical Center to the communities along the Niger River in Bamako, from the urban neighborhoods of Ségou to the rural villages of Sikasso — deserve honest, evidence-based information about cannabis medicine. We built our company not in a boardroom, but in the moments when our founder’s paralyzed dog Bentley got up and walked again after a CBD formula that veterinary medicine said was impossible. That same determination to find real solutions when conventional medicine falls short is what brings us to Mali today.

This guide is for the cancer patient in Kayes searching for alternatives after chemotherapy side effects become unbearable. For the veteran in Mopti managing PTSD when prescriptions stop working. For the elder in Gao with arthritis so severe that NSAIDs no longer touch the pain. For the caregiver in Kidal desperate for sleep after weeks of bedside vigil. We see you. We built this formula for you.

But first, we need to tell the truth about where RSO came from, what it actually is, and how we evolved it into something that can legally and safely reach your doorstep in Mali.

The Rick Simpson Story: From Nova Scotia to the Niger Bend

Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada. He wasn’t a doctor or a scientist — he was a power engineer and maintenance worker, a blue-collar tradesman like so many in Mali’s mining regions or construction sectors who understand what it means when the medical system fails you. His story resonates in Mali because we’ve all seen it: a worker injured on the job, prescribed medications that don’t work, then dismissed when they ask about alternatives.

In 1997, working at a hospital in Moncton, Simpson fell from scaffolding. The concussion left him with persistent tinnitus, dizziness, and post-concussion symptoms that conventional medicine couldn’t resolve. Sound familiar? In Mali’s urban centers and agricultural zones, workplace injuries are common, and access to specialist care can mean traveling hundreds of kilometers to Bamako — if you can afford it. Simpson’s doctor refused to discuss cannabis. Many Malian patients face similar institutional barriers, whether from cultural stigma or lack of physician training in cannabinoid medicine.

Simpson learned about a 1974 NIH-funded study at the Medical College of Virginia showing THC could slow tumor growth in mice. That study was never replicated in humans, but it sparked something. In 2003, Simpson claimed three bumps on his arm diagnosed as basal cell carcinoma disappeared after applying cannabis oil for four days. Important context: No independent medical verification exists. No biopsy confirmation. No clinical follow-up in any peer-reviewed journal. This is personal testimony, not medical evidence — but it’s historically significant because it launched a global movement.

After 2003, Simpson committed himself to producing and distributing oil for free. He helped people with cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, insomnia — the same conditions that drive Malians to search for alternatives today. His 2005 documentary Run From The Cure spread the concept worldwide, likely reaching West Africa through diaspora networks and online health communities.

But Simpson’s advocacy brought RCMP raids in 2005 and 2009. He was charged with cultivation, possession, and trafficking. The legal pressure eventually drove him from Canada to Europe. This matters in Mali because every country in West Africa has its own version of this story — people punished for cannabis before laws evolved. In Mali, cannabis remains strictly prohibited under the Loi n°2015-012, but hemp-derived products with <0.3% delta-9 THC occupy a different legal category that we operate within.

What Traditional RSO Actually Was: Transparency for Mali Consumers

Many products sold in Mali as “RSO” in underground markets or through informal channels bear no resemblance to Simpson’s original oil. Malian consumers deserve to know the difference.

Traditional RSO characteristics:

• Source material: Single high-THC indica strain, no standardization. In Mali’s climate, cannabis cultivation faces different challenges — variable rainfall, pest pressures, no standardized genetics.
• Extraction solvent: Naphtha (petroleum-based lighter fluid) or 99% isopropyl alcohol — neither food-grade. In Mali’s hot climate, residual solvent risks are even higher due to storage conditions.
• Process: Bucket, solvent, rice cooker evaporation. Simple but dangerous — fire risks, incomplete purging, no quality control. Imagine trying this in a Bamako apartment or a rural compound without ventilation.
• Appearance: Nearly black, tar-like, sticky. Strong cannabis odor with possible solvent-residual smell.
• Cannabinoid profile: 60-90% THC-dominant, fully decarboxylated. No ratio control. Every batch different. No lab verification.
• Terpene content: Essentially none — destroyed by heat and solvents.
• Standardization: Zero. No Certificate of Analysis (COA), no contaminant screening.
• Residual solvent risk: Naphtha may contain benzene, toluene — known carcinogens. In Mali’s regulatory environment, contaminated products pose serious health risks.

The protocol Simpson recommended:

• Goal: 60 grams over 90 days
• Week 1: Half a grain of rice size, three times daily (~30-45mg total)
• Weeks 2-5: Double every four days until reaching 1 gram daily
• Weeks 5-12: Maintain 1 gram daily (600-900mg THC)
• Methods: Oral (primary), topical for skin cancers, occasional inhalation for symptom relief
• Tolerance: Develops in 3-4 weeks. Initial psychoactive effects are temporary.

Critical context for Malian readers:

• This protocol was never validated in controlled trials.
• Daily THC exposure (600-900mg) far exceeds studied doses. The FDA-approved synthetic THC drug dronabinol is typically 2.5-20mg daily.
• Real risks at these doses: severe intoxication, anxiety, panic, tachycardia, blood pressure changes, cannabis use disorder. In Mali’s healthcare system, managing these complications may be difficult.

What Simpson Got Right and What He Overstated

What he got right:

• He drew attention to cannabinoids as serious medicine when the world ignored them.
• He created the political conditions for the legal cannabis industry that can now serve Mali.
• The term “RSO” remains the most recognized name for full-spectrum cannabis extract.

What he overstated:

• Cancer cure claims exceed the evidence. No human trial has proven RSO cures cancer.
• Encouraging patients to use RSO instead of proven oncologic therapies carries genuine harm potential. Delayed treatment is a documented concern.

For Malian cancer patients considering alternatives: we honor Simpson’s advocacy, but we prioritize your safety. RSO education should complement medical care, not replace it. If you’re receiving treatment at Bamako’s Hôpital du Mali or any oncology center, involve your medical team in any cannabinoid decisions.

The OilWell Difference: Built for Mali’s Reality

OilWell Cannabis was founded by Colin Valencia, who grew up in McAllen, Texas — a border region that shares more with Mali than you might think. Economic hardship, systemic challenges, violence, and limited opportunities outside retail and healthcare. Colin’s best friends were killed or imprisoned. He left home at sixteen. He chose cannabis over darker paths, then transitioned from the traditional underground market to a legal, legitimate business.

This matters for Mali because you understand resilience. You understand operating in difficult environments. You understand finding solutions when institutions fail.

The Bentley Story: Our Foundation

Bentley was Colin’s paralyzed dog, facing euthanasia. Veterinary medicine said nothing could be done. Colin created a CBD golden paste. Bentley got up, walked, and brought his ball. He lived ten more years, dying naturally at twenty.

During those ten years, Colin developed formulas for every condition Bentley faced:

• Neurodegeneration: CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection
• Dementia: CBC’s role in neurogenesis
• Glaucoma: THC’s CB1 agonism for intraocular pressure
• Arthritis: Multi-pathway anti-inflammation using CBD, CBG, THCa, and beta-caryophyllene

Single cannabinoids weren’t enough. Malian patients with multiple conditions understand this intuitively — a single pharmaceutical rarely addresses complex chronic illness.

Colin’s Personal Struggle: PTSD and Benzo Addiction

Colin used his cannabinoid knowledge to quit Xanax cold turkey — a notoriously dangerous feat. He created Peace Gummies during midnight experiments in benzo withdrawal. He personally uses the vape form for insomnia and severe PTSD.

This is not theoretical. This is lived experience. When we say these formulas help with PTSD, we speak from personal knowledge of the nightmare you’re living. Whether you’re a veteran from Mali’s northern conflicts, a survivor of trauma, or someone trapped in prescription cycles, we understand.

Our Four Core Principles for Mali

1. Accessibility Over Gatekeeping

In Mali, accessing specialized medical care often means traveling to Bamako, paying high fees, and navigating bureaucracy. Our model is different:

• No medical card required. Age 21+ only.
• Ships to Mali. We deliver nationwide across the U.S. and internationally to jurisdictions where hemp-derived products are legal. Mali’s legal framework for hemp products allows us to serve you.
• Same-day delivery in Houston’s Texas Medical Center — the world’s largest medical complex. We apply that same urgency to international orders for Malian patients.

2. Patient-Controlled Potency

Traditional RSO was always psychoactive. Our sublingual oil gives you three options:

• Raw (no heat): 1,500mg THCa stays non-psychoactive. Zero impairment. Perfect for daytime use, work, driving, parenting. In Mali’s hot climate, store in a cool place to prevent accidental decarboxylation.
• Fully activated (home decarb): Heat at 260°F (125°C) for 45-60 minutes. Converts 1,500mg THCa → ~1,315mg delta-9 THC. Combined with existing 90mg delta-9 THC = ~1,405mg total. This matches traditional illegal RSO potency. You control this transformation, not us.
• Vape (instant decarb): Each puff at 400-450°F instantly converts THCa to delta-9 THC. Fastest relief for breakthrough symptoms.

This flexibility matters in Mali’s diverse environments — farmers who need daytime function, urban workers who can’t be impaired, night-shift workers who need sleep support.

3. Open-Source Formulas

We publish our complete formulas publicly. If you can’t afford our product, source the ingredients and make your own. This echoes Simpson’s free-distribution ethos but adapts it for modern Mali.

The Original Bentley Recipe (Published Free):

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup coconut oil (unrefined, organic)
• 1-2 teaspoons freshly ground black pepper (for absorption)
• CBD oil (dosage per pet size)

Instructions: Mix turmeric and water into a paste over low heat (7-10 minutes). Add coconut oil and pepper. Cool, store refrigerated for up to 2 weeks. Mix with food.

We published this before our RSO formulas. We gave away the recipe that saved Bentley. We give away the RSO recipe too. For Malian pet owners facing similar crises, this is immediately actionable.

4. Evidence-Informed, Not Evidence-Overstating

We hold ourselves to the same standards we apply to everyone else. Our claims are anchored to peer-reviewed literature, not hype. When we say something works, we show you the evidence.

The Complete Science: What Every Malian Should Know

Research Method: How We Evaluate Evidence

Our evidence hierarchy is clear: human clinical evidence first, then systematic reviews, then institutional summaries (NIH, FDA, Health Canada), then preclinical literature. This matters because the evidence base is uneven:

• Strong human evidence: CBD (seizures), delta-9 THC (chemo nausea, HIV appetite)
• Emerging evidence: Delta-8 THC, THCa, CBG, CBN, CBC, terpenes
• Weak evidence: Many terpene-specific claims

We apply this to our own formulas. We don’t exempt ourselves.

Institutional Positions You Should Know

• U.S. National Cancer Institute (NCI): Acknowledges preclinical anticancer research but does not endorse cannabis as cancer treatment.
• U.S. FDA: Has not approved cannabis plant for cancer. Only Epidiolex (CBD) for seizures and synthetic THC for chemo nausea/HIV appetite are approved.
• Health Canada: Never approved RSO for cancer.
• NCCIH: Strongest evidence is for rare epilepsies, chemo nausea, HIV appetite — not cancer cure.

For Malian patients: If you’re receiving treatment at a facility like Hôpital du Point G in Bamako or any oncology center, these institutional positions matter. RSO should complement, not replace, proven therapies.

Cannabinoid Evidence Profiles

CBD (4,500mg in our formula):

• Strongest evidence: Seizure disorders (Epidiolex approved). This is the most credible indication.
• Anxiety: 2024 meta-analysis of 316 participants shows significant anxiolytic signal, but authors stress limited clinical sample and need for more trials [3].
• Pain: 2024 systematic review calls literature “promising but heterogeneous” — trial quality limits confidence [4].
• Sleep: 2023 review finds literature methodologically weak, mostly subjective measures [5].
• Safety: 2023 meta-analysis finds real signal for liver enzyme elevation and possible drug-induced liver injury, especially with concentrated oral products and polypharmacy [6]. Also: diarrhea, sleepiness, appetite changes, mood effects, and drug interactions [1].

CBG (3,000mg):

• Evidence: Mostly review-level and preclinical. Human evidence sparse [7][8].
• Pharmacology: CB2 agonist, alpha-2 adrenoceptor interactions, 5-HT1A signaling — mechanistically interesting but not clinically established [7].
• Research areas: Neurologic disorders, inflammatory bowel disease, antibacterial activity — all preclinical hypotheses [8].
• Caution: Commercially sold while evidence base remains thin. Claims outrun science [7].
• Bottom line: Promising minor cannabinoid, limited clinical validation [7][8].

Delta-8 THC (6,000mg):

• Evidence: Pharmacologically relevant, psychoactive, much less clinically characterized than delta-9 [9]-[11].
• Pharmacology: Partial CB1 agonist, cannabimimetic activity in animals and humans. Less potent than delta-9 due to weaker CB1 affinity [9].
• Public health: 2023 scoping review found evidence base dominated by animal studies, chemistry, use reports, and public-health concerns. Noted adverse consequences and regulatory/product-quality concerns [10].
• Manufacturing: Interest tied to stability and easier synthesis from hemp. Quality and byproduct concerns exist [11].
• Bottom line: Psychoactive THC analogue with real activity, incomplete safety characterization, more manufacturing uncertainty than consumers realize [9]-[11].

THCa (1,500mg):

• Evidence: Important chemically, low on direct human therapeutic evidence [12].
• What it is: Acidic THC precursor. Represents large share of raw plant THC content. Decarboxylates to THC during heating/storage [12].
• Psychoactivity: THCa itself is not psychoactive — but only if it stays acidic. Heating converts it [12].
• Research: In vitro/rodent literature suggests anti-inflammatory, immunomodulatory, neuroprotective, antineoplastic possibilities. Not established human outcomes [12].
• Bottom line: Highly relevant precursor molecule. Interpretation depends on route, temperature, processing, storage [12].

Delta-9 THC (90mg):

• Evidence: Strongest human evidence of psychoactive cannabinoids here, but clearest adverse-effect burden [1][13]-[15].
• Best supported: Chemo nausea/vomiting, HIV/AIDS appetite/weight loss, some MS/pain outcomes [1].
• Pain: 2022 systematic review: high-THC or balanced THC:CBD products may provide short-term pain benefit but increase dizziness, sedation, nausea, discontinuation [13].
• Pharmacokinetics: Inhaled: seconds-minutes onset, peaks 15-30 min, lasts few hours. Oral: later onset, later peak, longer duration. Critical for dosing [14].
• Mental health risk: 2025 review of high-concentration THC found consistent unfavorable associations with psychosis/schizophrenia and cannabis use disorder. Concerning signals for anxiety/depression in nontherapeutic settings [15].
• Broader safety: Anxiety/panic at high doses, tachycardia, blood pressure changes, dependency, withdrawal, pregnancy concerns, pediatric exposure, vape lung injury [1][14][15].
• Bottom line: Legitimate therapeutic relevance in some settings, but clear intoxication, psychiatric, and dose-related safety liabilities [1][13]-[15].

CBN (750mg):

• Evidence: Weak human evidence. Marketing ahead of data [12][16][17].
• What it’s marketed for: Sleep/sedation. Reputation widespread, clinical support thin [16][17].
• Sleep evidence: 2021 narrative review screened 99 human abstracts, reviewed 8 full-text articles. Found no clinical trials using validated sleep questionnaires or polysomnography to substantiate strong sleep claims [16].
• Broader sleep literature: 2024 updated review concluded overall cannabinoid sleep research doesn’t match real-world use scale. Need for better-designed, adequately powered trials remains substantial [17].
• Chemical context: THC degrades to CBN under certain conditions. Explains CBN’s presence in aging cannabis [12].
• Bottom line: Clearest example where cultural reputation stronger than clinical evidence [16][17].

CBC (750mg):

• Evidence: Emerging, intriguing, overwhelmingly preclinical/review-based [18][19].
• Pharmacology: 2024 review describes distinct pharmacodynamics, pharmacokinetics, receptor behavior. Highlights antinociceptive, antibacterial, anti-seizure as interesting targets [18].
• Older literature: Anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesia, possible neurobiological/antiproliferative relevance — all preclinical [19].
• Safety caveat: 2024 review notes over-the-counter CBC products sold despite little evidence establishing clinical efficacy or safety [18].
• Bottom line: Scientifically credible minor cannabinoid deserving more research, not already-validated clinical active [18][19].

Terpene Evidence Profiles

Limonene (citrus-bright):

• Evidence: Largely review/preclinical, useful safety literature [20]-[22].
• Activity: 2021 review describes antioxidant, anti-inflammatory, cardioprotective, gastroprotective, immune-modulatory — mostly nonhuman/non-cannabis literature [21].
• Safety: Limonene oxidation products (hydroperoxides) are clinically relevant contact allergens in patch-testing literature [22].
• Bottom line: Biologically active, widely discussed. Cannabis-specific therapeutic claims should stay conservative [20]-[22].

Myrcene:

• Evidence: Mostly preclinical, very limited human evidence [20][23].
• Research: 2021 review describes anxiolytic, antioxidant, anti-inflammatory, analgesic properties, mechanisms. Explicitly states human studies lacking [23].
• Caution: Often invoked as proven sedating terpene explaining couch-lock/sleep effects. Stronger claim than human evidence supports [20][23].
• Bottom line: Plausible bioactive terpene. Compound-specific clinical claims about mood, pain, sedation ahead of definitive human proof [23].

Caryophyllene (β-caryophyllene – pepper/spice):

• Evidence: Among most mechanistically interesting due to direct cannabinoid-system relevance, but mostly preclinical [24].
• Why it stands out: 2021 review describes as selective CB2 receptor agonist — unusual, makes it pharmacologically relevant beyond aroma [24].
• Research themes: Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective discussed. Human clinical confirmation limited [24].
• Bottom line: Arguably strongest candidate for terpene with cannabinoid-system significance, but should not be described as clinically proven for commonly attributed outcomes [24].

Pinene (forest-fresh):

• Evidence: Promising preclinical literature, weak human confirmation [20][25].
• Brain health framing: 2021 review on pinene and linalool as terpene-based medicines for brain health found antioxidant, anti-inflammatory, neuroprotective signals justifying future study. Emphasized evidence mostly preclinical, well-designed clinical trials lacking [25].
• Caution: Claims that pinene reliably improves memory, sharpens attention, or counterbalances THC cognitive effects remain interesting hypotheses, not settled clinical facts [20][25].
• Bottom line: Deserves scientific attention. Strong cognition-related claims should be presented as exploratory [25].

Linalool (floral, lavender):

• Evidence: Substantial preclinical interest, limited direct clinical confirmation [20][22][25][26].
• Research: Repeatedly discussed for stress, mood, brain-health pharmacology. 2021 brain-health review found enough preclinical signal to justify continued investigation in neurological/psychiatric contexts, while emphasizing lack of robust human trials [25].
• Additional literature: Separate review discusses possible antidepressant mechanisms, neuropharmacologic relevance — translational rather than definitive clinical story [26].
• Safety: Oxidized linalool hydroperoxides recognized allergens in dermatitis literature [22].
• Bottom line: Scientifically credible bioactive terpene. Current evidence supports cautious phrasing rather than firm therapeutic promises [22][25][26].

Humulene (earthy, woody):

• Evidence: Translationally interesting, still early [20][27].
• Scoping-review findings: 2024 review analyzed 340 articles, found broad preclinical evidence for anti-inflammatory and other biologic effects. Some rodent work suggested cannabimimetic properties via CB1 and adenosine A2a pathways [27].
• Caution: Findings valuable for hypothesis generation, but don’t yet establish consistent human efficacy across pain, inflammation, or mood outcomes [27].
• Bottom line: One of more interesting terpene research targets, but far from clinically settled [27].

Terpinolene (piney, fruity, sparkling):

• Evidence: One of least clinically characterized terpenes in this file [20][28].
• Systematic-review findings: 2021 review screened 2,449 records, included 57 studies. Concluded terpinolene has range of reported biological effects but evidence base still dominated by in silico, in vitro, and animal studies rather than human trials [28].
• Caution: Even recent cannabis entourage reviews frame terpene benefits as exploratory, not established compound-specific clinical effects [20].
• Bottom line: Biologically interesting, but among listed terpenes remains especially underdeveloped clinically [20][28].

Common Overstatements We Refuse to Make

1. CBN is a proven sleep aid → The sleep evidence for CBN remains weak, with no strong validated-trial base identified [16][17].
2. Myrcene is a proven human sedative → Myrcene has plausible preclinical bioactivity, but direct human proof for common claims is limited [20][23].
3. Terpenes have proven entourage effects in patients → Entourage hypotheses are influential but robust clinical proof remains limited and highly compound-specific [20][29].
4. THCa is always non-psychoactive → THCa itself is not THC, but heating and processing can convert THCa into THC, changing effective exposure [12].
5. Delta-8 THC is safe because it’s hemp-derived → Delta-8 THC is psychoactive, pharmacologically close to delta-9 THC, and often entangled with manufacturing and testing concerns [9]-[11].

How Our Formulas Connect to This Evidence

Every cannabinoid and terpene in our RSO has its evidence profile documented above. We don’t exempt ourselves from these standards. When we say our formula contains 4,500mg CBD, we reference the seizure evidence [1][2], the anxiety meta-analysis [3], the pain review [4], the sleep literature limitations [5], and the liver safety concerns [6]. When we include 750mg CBN, we acknowledge the sleep evidence is weak [16][17]. When we include 750mg CBC, we note it’s emerging and preclinical [18][19].

This is what transparency looks like. In Mali’s marketplace, where claims often outrun evidence, we offer something different: the complete picture.

Our RSO Formulas: The Open-Source Blueprint

We publish everything. This is the actual formula that ships from Houston to Mali.

RSO Sublingual Oil — $129.99

Cannabinoid	Amount
CBD	4,500mg
CBG	3,000mg
Delta-8 THC	6,000mg
THCa	1,500mg
Delta-9 THC	90mg
CBN	750mg
CBC	750mg
Total Cannabinoids	16,590mg

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Format: 30mL bottle
• Carrier: Organic MCT oil
• Active cannabinoids per mL: 553mg
• Graduated dropper: Precise dosing in 0.1mL increments
• Onset: 15-45 minutes (sublingual)
• Peak: 1-2 hours
• Duration: 4-6 hours
• Bioavailability: 13-19%
• Doses per bottle: 40-60 depending on serving size

For Malian buyers: This represents roughly 16.6 grams of total cannabinoids — far more concentrated than traditional RSO’s 60-90% THC (which is only one compound). You’re getting seven cannabinoids at specific ratios. The price ($129.99) reflects the cost of sourcing seven distillates, third-party testing, and small-batch production in Houston. For those who cannot afford this, the formula above is your recipe to source and make yourself.

RSO Vape Cartridge — $49.99

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%+
• Format: 1 Gram cartridge
• Battery: 510-thread universal compatibility (available in Mali’s electronics markets)
• Onset: 1-2 minutes (fastest delivery)
• Peak: 10-15 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35%
• Auto-decarb: Vaping at 400-450°F instantly converts THCa → delta-9 THC

For Malian users: The vape format is ideal for acute breakthrough pain, panic attacks, or nausea when you need relief in 60-120 seconds. It requires a 510-thread battery (widely available). In Mali’s climate, store cartridges upright in cool, dark places to preserve terpenes.

Condition-Specific Usage Context for Mali

Critical disclaimer: These contexts are informed by research cited above. They are NOT medical prescriptions, NOT FDA-approved, and NOT substitutes for professional care. These products have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Always consult a healthcare provider before use, especially if you have medical conditions, take medications, are pregnant/nursing, or have health concerns. Do not operate vehicles or machinery while impaired.

General principle for Malian users: Start low, go slow. Begin 0.25-0.5mL sublingual. Assess effects over 2-3 hours before increasing. Individual response varies by weight, metabolism, tolerance, medications, and genetics.

Chemotherapy-Related Nausea and Appetite Support in Mali

• Pre-chemo: 0.5-1.0mL sublingual ~1 hour before treatment at Bamako’s oncology centers
• Acute breakthrough nausea: 2-3 vape puffs for immediate relief (1-2 minute onset)
• Post-chemo: 0.5mL sublingual every 6 hours as needed
• Sleep support during treatment: 1.0-2.0mL sublingual before bed (delivers 25-50mg CBN)
• Evidence: Delta-8 antiemetic [9], delta-9 THC nausea [1][13], CBD anxiolytic buffering [3]

Chronic Pain (Fibromyalgia, Arthritis, Neuropathy) in Mali

• Daytime: 0.3-0.5mL raw sublingual — anti-inflammatory without impairment for farmers, traders, workers
• Nighttime: 0.5-1.0mL decarboxylated sublingual — combines pain relief with CBN sleep support
• Breakthrough pain: Vape as needed for rapid onset
• Evidence: CBD pain [4], delta-9 THC pain [13], beta-caryophyllene CB2 agonism [24], THCa COX-2 inhibition [12]

Sleep Support in Mali’s Climate

• Before bed: 1.0-2.0mL sublingual
• At 2.0mL: Delivers 50mg CBN — dosage investigated in 2024 sleep literature
• At 1.0mL: Delivers 25mg CBN — above threshold associated with reduced sleep disturbance
• Evidence: CBN sleep evidence is weak [16][17], but included for its theoretical role. The broader cannabinoid profile matters more for sleep architecture.

Anxiety and Stress in Malian Context

• Daytime functional relief: 0.3mL raw sublingual — CBD and CBG address anxiety pathways without impairment
• Nighttime: 1.0mL sublingual — full profile including CBN for sleep architecture
• Evidence: CBD anxiety [3], CBG pharmacology [7][8], limonene entourage [20]

When to Use Each Format in Mali

Use Case	Recommended Format	Rationale
Fast relief (acute pain, nausea, panic)	Vape	1-2 minute onset critical for breakthrough symptoms
Sustained relief (chronic pain, sleep)	Sublingual	4-6 hour duration avoids frequent redosing
Maximum bioavailability	Sublingual	13-19% absorption, partially bypasses liver
Portability/discretion	Vape	Compact, no measuring in public spaces
Precise dosing	Sublingual	0.1mL increments allow fine-tuning
Daytime non-psychoactive	Sublingual (raw)	THCa stays inactive, zero impairment for work
Nighttime psychoactive	Sublingual (decarbed) or Vape	Activated THCa + delta-8 THC for therapeutic strength

Competitive Comparison: Why OilWell for Mali

OilWell RSO vs. Traditional Illegal RSO in Mali

Dimension	Traditional RSO (Mali black market)	OilWell RSO
Cannabinoid profile	THC-only, 60-90% variable	7 cannabinoids, specific ratios, 553mg/mL total
CBG/CBN/CBC content	Minimal to none	3,000mg CBG, 750mg CBN, 750mg CBC
Patient-controlled potency	No — always psychoactive	Yes — choose raw, decarbed, or vape
Access requirements	Black market risk, legal danger	Age 21+, ships to Mali, Farm Bill compliant
Lab testing	None — unknown contaminants	Full panel: potency, terpenes, pesticides, heavy metals, residual solvents, microbial
Delivery	Risky, inconsistent, no recourse**	Tracked shipping, COAs, customer support
Safety	Residual naphtha/solvents	Solvent-free, organic MCT oil base

For Malian consumers: The black market RSO available in Bamako, Koulikoro, or through regional networks cannot match this safety profile. Unknown solvents, zero testing, and legal risk make it dangerous.

OilWell RSO vs. CBD-Only Products (if available in Mali)

Dimension	Typical CBD Product	OilWell RSO
Total cannabinoids	1,000mg	16,590mg
CBD content	~950mg	4,500mg
CBG/CBN/CBC	Trace or none	3,000mg/750mg/750mg
Delta-8 THC	0mg	6,000mg
THCa (convertible)	Minimal	1,500mg → ~1,315mg delta-9 THC
Psychoactive option	No	Yes — you choose
Price	$40-50	$129.99

For Malian buyers: The price difference reflects 16.5x more total cannabinoids, seven compounds instead of one, and the ability to activate psychoactive effects legally.

Legal Status for Malian Customers

Our RSO Sublingual Oil contains only 90mg delta-9 THC in the entire 30mL bottle — 3mg/mL, well under the 0.3% federal threshold. All cannabinoids are hemp-derived.

Farm Bill Compliance: The 2018 U.S. Farm Bill legalized hemp products with <0.3% delta-9 THC. This federal framework enables international shipping to jurisdictions with compatible hemp laws.

Mali’s Legal Framework: Under Malian Loi n°2015-012, cannabis (marijuana) remains strictly prohibited. However, hemp-derived products with <0.3% delta-9 THC occupy a different category. Our product meets this standard at point of sale.

Critical for Malian customers: THCa converts to delta-9 THC when heated. While our product is legal as shipped, you are responsible for understanding and complying with Malian laws regarding possession and use of decarboxylated products. We provide full documentation, COAs, and receipts for customs. International customers accept all customs and legal risk.

Disclaimers required by Malian and international law:

• Not evaluated by FDA
• Not intended to diagnose, treat, cure, or prevent any disease
• Consult healthcare provider before use
• Individual results may vary
• May cause drowsiness or impairment
• Do not operate vehicles or machinery while impaired
• Consult physician if pregnant or nursing
• Keep out of reach of children
• Buyer responsible for checking local laws
• Void where prohibited

Delivery to Mali: How It Works

OilWell operates from Houston but ships worldwide. Here’s exactly how Malian customers receive our products:

Ordering Process:

1. Visit our website: https://oilwellcbd.com/thca-rick-simpson-oil-rso-by-oilwell-cannabis-of-houston-texas/
2. Select RSO Sublingual Oil ($129.99) or Vape Cartridge ($49.99)
3. Enter Mali shipping address
4. International shipping fee applies (minimum flat rate; excessive costs billed separately)
5. Payment processed securely
6. Order ships with full documentation, COAs, and customs forms

Shipping Details:

• Carrier: USPS Priority Mail International, FedEx International, or UPS Worldwide
• Timeline: 7-21 business days depending on customs processing in Bamako
• Tracking: Provided for all orders
• Packaging: Discreet, no cannabis branding visible
• Temperature stability: Products are shelf-stable at Mali’s ambient temperatures, but store in cool, dark place to preserve terpenes
• Customs: You accept all customs risk. We provide complete documentation to facilitate clearance at Bamako-Sénou International Airport or other entry points.

PANDEM1C SEO Technology: Our proprietary system with 14 million geopolitical locations and 300+ AI models drives organic visibility, making OilWell discoverable to Malian patients searching in English or French for terms like “huile RSO Mali,” “cannabis médical Bamako,” or “traitement douleur chronique Mali.”

Contact for Malian customers:

• Phone: +1 (832) 416-2816 (WhatsApp available for international customers)
• Email: [email protected]
• Instagram: @oilwellcbd (DM for Mali-specific questions)

The Seven ABC13 Features: Our Credibility for Mali

Between 2019-2023, ABC13 Houston featured OilWell in seven news segments. Why does this matter for Malian customers? Because mainstream media validation from a major U.S. network affiliate is independently verified credibility — not our marketing. This recognition cannot be purchased; it can only be earned.

September 2019: “I’m not trying to sell people snake oil”
Our foundational quote: “There’s enough research that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

March 2021: “Pain comes in a lot of different forms”
We helped other entrepreneurs like Jonathan Pina enter legal cannabis. We understand that Malian pain — from physical labor, conflict trauma, chronic illness — is multifaceted.

May 2021: “Maybe you want to get high”
Steve Campion’s investigative feature on delta-8. Our radical honesty: “I don’t give a sh** if it’s wrong to say you’ll get high off it. Maybe you want to get high.” In Mali, where cannabis discussions are often shrouded in euphemism, we speak plainly.

August 2021: $35,000 COVID vaccine giveaway
We gave away 1,000 caviar pre-rolls to encourage vaccination in Houston. Community health action, not profit.

October 2021: Proactive Delta-8 removal
When Texas banned delta-8 overnight, we removed all products before enforcement and warned other operators. Ethical leadership during crisis.

October 2022: Biden pardon reveals Colin’s conviction
“I would love to see people not get hurt for this anymore.” Our founder’s personal cannabis conviction history makes every quote more powerful. We’ve lived the consequences.

April 2023: “Right now is a Renaissance”
Growing hemp on camera, explaining Texas medical cannabis limitations. We lead by doing.

Why OilWell Is Different in Mali’s Market

Mali’s cannabis landscape is fragmented — underground RSO, unverified CBD products, no testing infrastructure, legal ambiguity. We offer:

1. Complete transparency: Every milligram published. No other company does this.
2. Third-party testing: Heavy metals, pesticides, residual solvents, microbial contaminants. We test for what Malian consumers cannot see.
3. Legal shipping: Hemp-derived, Farm Bill compliant, documented for customs.
4. Patient control: You decide psychoactivity. Not us.
5. Open-source: Can’t afford it? Make it yourself. We give you the recipe.
6. Evidence-based: 29 peer-reviewed citations backing every claim in this document.

Our Promise to Mali

We are not here to sell snake oil. We are not here to sell hope. We are here to give you the best possible version of the information and the product so you can give it a fair shot — whether it’s right or wrong for you.

Bentley’s story taught us that cannabinoids can do what pharmaceuticals cannot. Colin’s benzo withdrawal taught us that these formulas can save lives. The ABC13 features taught us that mainstream credibility matters. The science teaches us to stay humble and honest.

From Houston’s Montrose neighborhood to your home in Bamako, Ségou, Mopti, Gao, Kayes, or Kidal — we bring you the most thoughtfully formulated, transparently produced, and honestly presented RSO available anywhere in the world.

The same legal product can be non-psychoactive anti-inflammatory medicine for your daytime work in the fields, or full-potency therapeutic support for your nighttime pain. You choose. That’s what patient control means.

We ship to Mali. We test every batch. We publish every formula. We answer every question.

Order today: https://oilwellcbd.com/thca-rick-simpson-oil-rso-by-oilwell-cannabis-of-houston-texas/
Contact us: [email protected] | +1 (832) 416-2816
Follow: @oilwellcbd on Instagram

This is more than a brand. This is the mission that started when Bentley got up and walked. This is for you, Mali.

---